YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | MoonLake Immunotherapeutics - Ordinary Shares - Class A | Chief Scientific Officer | 1.3 M | 5.9 % |
2023 | MoonLake Immunotherapeutics - Ordinary Shares - Class A | Chief Scientific Officer | 1.2 M | -73.0 % |
2022 | MoonLake Immunotherapeutics - Ordinary Shares - Class A | Chief Scientific Officer | 4.6 M | - |
2021 | MoonLake Immunotherapeutics - Ordinary Shares - Class A | - | 5.2 M | - |
2021 | MoonLake Immunotherapeutics - Ordinary Shares - Class A | Chief Scientific Officer | - | - |